Assembly Biosciences Inc expected to post a loss of $2.23 a share - Earnings Preview

Assembly Biosciences

05/08/2024 13:42

* Assembly Biosciences Inc  ASMB.OQ   ASMB.O  is expected
to show
a rise in quarterly revenue when it reports  results on August 7
(estimated) for the period ending June 30 2024
    * The South San Francisco California-based  company is
expected to
report revenue of $5.959 million, according to the estimate from
one analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for Assembly Biosciences Inc
is
for a loss of $2.23 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $36.00​, above​ its last closing price
of $14.29. ​​​

This summary was machine generated August 5 at 12:42 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)